127 related articles for article (PubMed ID: 38335308)
1. Cell Membrane-Targeting Type I/II Photodynamic Therapy Combination with FSP1 Inhibition for Ferroptosis-Enhanced Photodynamic Immunotherapy.
Chen J; Duan Z; Deng L; Li L; Li Q; Qu J; Li X; Liu R
Adv Healthc Mater; 2024 Feb; ():e2304436. PubMed ID: 38335308
[TBL] [Abstract][Full Text] [Related]
2. Photo-Enhanced Synergistic Induction of Ferroptosis for Anti-Cancer Immunotherapy.
Zhou Y; Chen K; Lin WK; Liu J; Kang W; Zhang Y; Yang R; Jin L; Cheng Y; Xu A; Wang W
Adv Healthc Mater; 2023 Oct; 12(27):e2300994. PubMed ID: 37432874
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic Therapy Combined with Ferroptosis Is a Synergistic Antitumor Therapy Strategy.
Huang Y; Li X; Zhang Z; Xiong L; Wang Y; Wen Y
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894410
[TBL] [Abstract][Full Text] [Related]
5. Lipid Droplet Targeting Type I Photosensitizer for Ferroptosis via Lipid Peroxidation Accumulation.
Xiong T; Chen Y; Peng Q; Lu S; Long S; Li M; Wang H; Lu S; Chen X; Fan J; Wang L; Peng X
Adv Mater; 2024 Jan; 36(4):e2309711. PubMed ID: 37983647
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Photodynamic Therapy Synergizing with Inhibition of Tumor Neutrophil Ferroptosis Boosts Anti-PD-1 Therapy of Gastric Cancer.
Zhu X; Zheng W; Wang X; Li Z; Shen X; Chen Q; Lu Y; Chen K; Ai S; Zhu Y; Guan W; Yao S; Liu S
Adv Sci (Weinh); 2024 Mar; 11(12):e2307870. PubMed ID: 38233204
[TBL] [Abstract][Full Text] [Related]
8. Study of Iron Complex Photosensitizer with Hollow Double-Shell Nano Structure Used to Enhance Ferroptosis and Photodynamic Therapy.
Cai X; Liu W; Zhang J; Li Z; Liu M; Hu S; Luo J; Peng K; Ye B; Wang Y; Yan R
Small; 2024 Feb; ():e2309086. PubMed ID: 38321834
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
[TBL] [Abstract][Full Text] [Related]
10. An Electron Donor-Acceptor Structured Rhenium(I) Complex Photo-Sensitizer Evokes Mutually Reinforcing "Closed-Loop" Ferroptosis and Immunotherapy.
Ren Q; Wang H; Li D; Dao A; Luo J; Wang D; Zhang P; Huang H
Adv Healthc Mater; 2024 Apr; ():e2304067. PubMed ID: 38597369
[TBL] [Abstract][Full Text] [Related]
11. Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis.
Xiao X; Chen M; Zhang Y; Li L; Peng Y; Li J; Zhou W
J Nanobiotechnology; 2022 Sep; 20(1):410. PubMed ID: 36109814
[TBL] [Abstract][Full Text] [Related]
12. BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1.
Fan C; Guo X; Zhang J; Zheng W; Shi C; Qin Y; Shen H; Lu Y; Fan Y; Li Y; Chen L; Mao R
Discov Oncol; 2024 Apr; 15(1):98. PubMed ID: 38565708
[TBL] [Abstract][Full Text] [Related]
13. Engineering nanoenzymes integrating Iron-based metal organic frameworks with Pt nanoparticles for enhanced Photodynamic-Ferroptosis therapy.
Ye Y; Yu H; Chen B; Zhao Y; Lv B; Xue G; Sun Y; Cao J
J Colloid Interface Sci; 2023 Sep; 645():882-894. PubMed ID: 37178565
[TBL] [Abstract][Full Text] [Related]
14. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation.
Müller F; Lim JKM; Bebber CM; Seidel E; Tishina S; Dahlhaus A; Stroh J; Beck J; Yapici FI; Nakayama K; Torres Fernández L; Brägelmann J; Leprivier G; von Karstedt S
Cell Death Differ; 2023 Feb; 30(2):442-456. PubMed ID: 36443441
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Induces Ferroptosis in A549 CD133
Zhou J; Zhang L; Yan J; Hou A; Sui W; Sun M
Discov Med; 2023 Jun; 35(176):251-263. PubMed ID: 37272092
[TBL] [Abstract][Full Text] [Related]
16. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
[TBL] [Abstract][Full Text] [Related]
17. Phase separation of FSP1 promotes ferroptosis.
Nakamura T; Hipp C; Santos Dias Mourão A; Borggräfe J; Aldrovandi M; Henkelmann B; Wanninger J; Mishima E; Lytton E; Emler D; Proneth B; Sattler M; Conrad M
Nature; 2023 Jul; 619(7969):371-377. PubMed ID: 37380771
[TBL] [Abstract][Full Text] [Related]
18. Plasma-activated medium induces ferroptosis by depleting FSP1 in human lung cancer cells.
Jo A; Bae JH; Yoon YJ; Chung TH; Lee EW; Kim YH; Joh HM; Chung JW
Cell Death Dis; 2022 Mar; 13(3):212. PubMed ID: 35256587
[TBL] [Abstract][Full Text] [Related]
19. QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1
Cao H; Wu X; Gao R; Chen L; Feng Y; Wang D
J Cancer; 2023; 14(12):2236-2245. PubMed ID: 37576395
[TBL] [Abstract][Full Text] [Related]
20. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
